These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8096489)

  • 1. Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in endometrial carcinoma with argyrophil cells.
    Ueda G; Sawada M; Ogawa H; Tanizawa O; Tsujimoto M
    Gynecol Oncol; 1993 Mar; 48(3):314-6. PubMed ID: 8096489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in gynecological tumors and their related lesions].
    Sawada M; Ueda G; Inoue M; Shimizu H; Ogawa H; Nakazawa A; Fujita M; Tanizawa O; Tsujimoto M
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):181-7. PubMed ID: 1347557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferating cell nuclear antigen in archival surgical specimens of malignant lymphoma and metastatic carcinoma: immunohistochemical and flow cytometric analysis.
    Gorczyca W; Kram A; Tuziak T; Darzynkiewicz Z; Melamed MR
    Patol Pol; 1993; 44(3):121-8. PubMed ID: 7902557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proliferating cell nuclear antigen/cyclin (PCNA/Cyclin) in thyroid carcinoma].
    Xu YJ
    Zhonghua Wai Ke Za Zhi; 1993 Oct; 31(10):628-9. PubMed ID: 7913437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
    Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
    Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferating cell nuclear antigen in endometrial carcinoma: pretreatment identification of high-risk patients.
    Garzetti GG; Ciavattini A; Goteri G; De Nictolis M; Romanini C
    Gynecol Oncol; 1996 Apr; 61(1):16-21. PubMed ID: 8626110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical demonstration of HNK-1-defined antigen in gynecologic tumors with argyrophilia.
    Ueda G; Yamasaki M; Inoue M; Tanaka Y; Inoue Y; Abe Y; Tanizawa O
    Int J Gynecol Pathol; 1986; 5(2):143-50. PubMed ID: 2424852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
    Griffey SM; Kraegel SA; Madewell BR
    J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of proliferating cell nuclear antigen (PCNA) index and microvessel density (MVD) in endometrial carcinoma].
    Xiao L; Tang LD
    Ai Zheng; 2005 Jan; 24(1):19-22. PubMed ID: 15642194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma.
    Hamid AA; Mandai M; Konishi I; Nanbu K; Tsuruta Y; Kusakari T; Kariya M; Kita M; Fujii S
    Cancer; 2002 Feb; 94(4):997-1005. PubMed ID: 11920468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferating cell nuclear antigen (PCNA/cyclin) in plant proliferating cells: immunohistochemical and quantitative analysis using autoantibody and murine monoclonal antibodies to PCNA.
    Daidoji H; Takasaki Y; Nakane PK
    Cell Biochem Funct; 1992 Jun; 10(2):123-32. PubMed ID: 1352740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications.
    Yu CC; Filipe MI
    Histochem J; 1993 Dec; 25(12):843-53. PubMed ID: 7906685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables.
    Frierson HF
    Mod Pathol; 1993 May; 6(3):290-4. PubMed ID: 8102204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The evaluation of cellular proliferating activity in gastric carcinoma with the proliferating cell nuclear antigen (PCNA) expressive rate: its fundamental examination of the immunohistochemical procedures and its clinical applications].
    Nakano H; Namatame K; Nakayoshi A; Kumada K
    Nihon Geka Gakkai Zasshi; 1993 Jun; 94(6):580-92. PubMed ID: 8101959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma.
    Hamel NW; Sebo TJ; Wilson TO; Keeney GL; Roche PC; Suman VJ; Hu TC; Podratz KC
    Gynecol Oncol; 1996 Aug; 62(2):192-8. PubMed ID: 8751548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of proliferative cells.
    Mokrý J; Nĕmecek S
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 and PCNA immunoexpression in endometrial carcinomas.
    Simionescu C; Georgescu CV; Mărgăritescu C; Bălă S; Marinescu M; Enăchescu V; Pătru E
    Rom J Morphol Embryol; 2006; 47(2):137-41. PubMed ID: 17106521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer.
    Gu C; Oyama T; Osaki T; Kohno K; Yasumoto K
    Anticancer Res; 2001; 21(4A):2357-62. PubMed ID: 11724293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.
    Sonoda K; Kaku T; Hirakawa T; Kobayashi H; Amada S; Sakai K; Nakashima M; Watanabe T; Nakano H
    Gynecol Oncol; 2000 Dec; 79(3):424-9. PubMed ID: 11104614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.